Cypress initiates phase II program for milnacipran in fibromyalgia syndrome Feb. 26, 2002 No Comments
FDA approves Zometa for bone metastases from solid tumors and multiple myeloma Feb. 26, 2002 No Comments
GlaxoSmithKline launches environmentally friendly reformulation of Ventolin Feb. 22, 2002 No Comments